SVISS LABSS PVT LTD

Name

SVISS LABSS PVT LTD

Legal name

Sviss Labss Private Limited

Website

https://svisslabss.net

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL), Manufacturing Quality, GMP Inspections & Compliance (HLAJADAG)

Keywords

• Pharmaceutical contract manufacturing
• Active pharmaceutical ingredients
• API intermediates production
• Ibuprofen drug intermediates
• Bulk drug manufacturing

Headquarters

HQ city

Ranipet

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Contract Manufacturing Services: SVISS LABSS provides contract manufacturing services for Active Pharmaceutical Ingredients and intermediates to pharmaceutical companies, leveraging their infrastructure and technical capabilities. The company synergizes its manufacturing skills with the marketing and financial strengths of leading pharmaceutical companies.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

SVISS LABSS is a contract manufacturer of Active Pharmaceutical Ingredients (APIs) and API Intermediates, with a primary focus on Ibuprofen Stage-I produced through Acylation and Friedel-Crafts Reaction processes. The company operates a GMP-compliant (US FDA and WHO) and ISO 9001:2015-certified facility in Ranipet, Tamil Nadu, providing cost-effective, quality-focused contract manufacturing services to leading pharmaceutical companies for both domestic and export markets.

Product overview

SVISS LABSS is a pharmaceutical contract manufacturing company specializing in the production of Active Pharmaceutical Ingredients (APIs) and API Intermediates. The company's primary product offering is Ibuprofen Stage-I, which is manufactured using specialized chemical processes including Acylation and Friedel-Crafts Reaction. The company operates a 28,000 Sq.Ft. manufacturing facility equipped with glass-lined reactors, SS reactors, and HDPE reactors, providing contract manufacturing services to leading pharmaceutical companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Ibuprofen Stage-I Active Pharmaceutical Ingredient (API) intermediate produced through specialized chemical synthesis processes including Acylation and Friedel-Crafts Reaction, supplied to leading pharmaceutical companies for further drug manufacturing.
• Contract Manufacturing Services for APIs and Intermediates

Quantifiable outcome

• Steady 10% growth rate over successive years
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Leading Pharmaceutical CompaniescoreStrategic or Co-development PartnerSVISS LABSS has strategic associations with leading pharmaceutical companies, leveraging their marketing and financial strengths. This association led to a strategic shift in the business model to contract manufacturing services and was a major turning point in the company's corporate life, aligning operations with globalization trends.

Scale indicators6 records

Recent moves8 records

Expansion highlights3 records

Broad incumbents

• Granules India: Indian vertically integrated manufacturer of APIs, intermediates, and finished pharmaceutical formulations with significant exports. Comparable to SVISS LABSS as a domestic API intermediates producer, though Granules operates at much larger scale and offers finished dosages as well.
• Laurus Labs: Hyderabad-based API and CDMO company supplying small-molecule APIs and intermediates globally, including NSAIDs. Relevant comparator to SVISS LABSS as a larger Indian small-molecule CDMO with similar customer types (global pharma) and similar export-led model.
• Cambrex Corporation: Established US-headquartered CDMO providing small-molecule API development and manufacturing services. Comparable to SVISS LABSS as a small-molecule API contract manufacturer with GMP facilities serving global pharma, though at much larger footprint and broader customer base.
• Piramal Pharma Solutions: Global CDMO division of Piramal Pharma providing API development and manufacturing including small-molecule active ingredients. Comparable to SVISS LABSS as a CDMO peer in small-molecule API manufacturing, but at significantly larger scale and broader service offering including biologics.
• Divis Laboratories: Indian-listed API and intermediates manufacturer with a large contract manufacturing footprint across multiple therapeutic categories. Comparable to SVISS LABSS as a domestic API/CDMO peer, but operating at materially larger scale and across a broader molecule portfolio.

Direct peers

• Hikal Ltd: Mumbai-based contract manufacturer of APIs, intermediates, and fine chemicals serving global pharma and agrochemical customers. Closely comparable to SVISS LABSS in business model (contract manufacturing of small-molecule intermediates), customer base (multinational pharma), and end-markets (regulated and semi-regulated APIs).
• Neuland Labs: India-based contract manufacturer focused on small-molecule APIs and intermediates. Directly comparable to SVISS LABSS as a focused Indian CDMO serving pharma customers with custom synthesis and manufacturing, though Neuland operates at meaningfully larger scale and has USFDA-inspected facilities.
• Sai Life Sciences: India-based CDMO providing contract development and manufacturing services for small-molecule APIs and intermediates to global pharma customers. Directly comparable to SVISS LABSS as a contract manufacturer serving international pharma with custom synthesis capabilities and GMP certifications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sviss-labss

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SVISS LABSS PVT LTD